Alexander Haug
MedUni Wien, Universitätsklinik für Radiologie und Nuklearmedizin, , Austria
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
Initial experience with aggressive treatment of metastastic prostate cancer using 3 cycles of 7.4 GBq [177Lu]-PSMA every 4 weeks (#28)
2:00 PM
Alexander Haug
A New Era of Prostate Cancer Imaging - (submitted abstract)
Phase I/II open-label trial to evaluate the safety and preliminary efficacy of 177Lu-OPS201, a radiolabeled somatostatin receptor antagonist, in patients with somatostatin receptor-positive, progressive gastroenteropancreatic neuroendocrine tumors (#57)
8:30 AM
Rod Hicks
Conference Breakfast: Moderated Poster Walk - Neuroendocrine tumours